|
|
Article: Viron Raises $25M In Series A For Viral Protein Therapeutics.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
As it leverages the evolutionary process of viral proteins, creating drugs for anti-inflammatory diseases, Viron Therapeutics Inc. closed a $20 million Series A financing.
Founded in 1997 as a spinout of Canada's Robarts Research Institute, the company has previously raised up to C$15 million (US$13.5 million) through bridge and mezzanine financings, but it recapitalized a year and a half ago to make itself more inviting to investors.
The $20 million round was oversubscribed and, when added to an additional investment of about $4.5 million coming from the Canadian government through its Technology Partnerships Canada program, ...